pharmaceutical investing OncoMed Announces Second Quarter 2018 Financial Results and Operational Highlights
pharmaceutical investing OncoMed Announces Fourth Quarter and Full Year 2017 Financial Results and Operational Highlights
Appoints global biopharma leader Paul Carter as Non-Executive Director to support next phase of strategic growth
Apex Commences Drilling at Jersey Emerald Property and Announces Amendment to Terms of Lithium Creek Option Agreement